Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 1

Results: 19

Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 229, doi. 10.1007/s00262-021-02980-x
By:
- Fukuokaya, Wataru;
- Kimura, Takahiro;
- Yanagisawa, Takafumi;
- Kimura, Shoji;
- Tsuzuki, Shunsuke;
- Koike, Yuhei;
- Iwamoto, Yuya;
- Enei, Yuki;
- Tanaka, Masatoshi;
- Urabe, Fumihiko;
- Onuma, Hajime;
- Honda, Mariko;
- Miki, Jun;
- Oyama, Yu;
- Abe, Hirokazu;
- Egawa, Shin
Publication type:
Article
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 203, doi. 10.1007/s00262-021-02979-4
By:
- Karayama, Masato;
- Inui, Naoki;
- Inoue, Yusuke;
- Yoshimura, Katsuhiro;
- Mori, Kazutaka;
- Hozumi, Hironao;
- Suzuki, Yuzo;
- Furuhashi, Kazuki;
- Fujisawa, Tomoyuki;
- Enomoto, Noriyuki;
- Nakamura, Yutaro;
- Asada, Kazuhiro;
- Uto, Tomohiro;
- Fujii, Masato;
- Matsui, Takashi;
- Matsuura, Shun;
- Hashimoto, Dai;
- Toyoshima, Mikio;
- Kusagaya, Hideki;
- Matsuda, Hiroyuki
Publication type:
Article
ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 219, doi. 10.1007/s00262-021-02974-9
By:
- Mao, Shiqi;
- Zhou, Fei;
- Liu, Yiwei;
- Yang, Shuo;
- Chen, Bin;
- Xu, Jian;
- Wu, Fengying;
- Li, Xuefei;
- Zhao, Chao;
- Wang, Wanying;
- Liu, Qian;
- Yu, Xiaofei;
- Jia, Keyi;
- Shao, Chuchu;
- Zhou, Caicun;
- Gao, Guanghui;
- Ren, Shengxiang
Publication type:
Article
Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 165, doi. 10.1007/s00262-021-02971-y
By:
- Butler, Savannah E.;
- Brog, Rachel A.;
- Chang, Cheryl H.;
- Sentman, Charles L.;
- Huang, Yina H.;
- Ackerman, Margaret E.
Publication type:
Article
CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 137, doi. 10.1007/s00262-021-02969-6
By:
- Yamauchi, Takayoshi;
- Hoki, Toshifumi;
- Oba, Takaaki;
- Kajihara, Ryutaro;
- Attwood, Kristopher;
- Cao, Xuefang;
- Ito, Fumito
Publication type:
Article
SIRPα-specific monoclonal antibody enables antibody-dependent phagocytosis of neuroblastoma cells.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 71, doi. 10.1007/s00262-021-02968-7
By:
- Bahri, Meriem;
- Kailayangiri, Sareetha;
- Vermeulen, Sarah;
- Galopin, Natacha;
- Rossig, Claudia;
- Paris, François;
- Fougeray, Sophie;
- Birklé, Stéphane
Publication type:
Article
Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 121, doi. 10.1007/s00262-021-02967-8
By:
- Liu, Lulu;
- Zhang, Ruyi;
- Deng, Jingwen;
- Dai, Xiaomeng;
- Zhu, Xudong;
- Fu, Qihan;
- Zhang, Hangyu;
- Tong, Zhou;
- Zhao, Peng;
- Fang, Weijia;
- Zheng, Yi;
- Bao, Xuanwen
Publication type:
Article
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 111, doi. 10.1007/s00262-021-02966-9
By:
- Wang, Yanni;
- Chen, Huan;
- Jiao, Xi;
- Wu, Lihong;
- Yang, Ying;
- Zhang, Jiao;
- Wu, Lijia;
- Liu, Chang;
- Zhuo, Na;
- Li, Shuang;
- Gong, Jifang;
- Li, Jian;
- Zhang, Xiaotian;
- Wang, Xicheng;
- Peng, Zhi;
- Qi, Changsong;
- Wang, Zhenghang;
- Li, Jie;
- Li, Yan;
- Lu, Zhihao
Publication type:
Article
Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 153, doi. 10.1007/s00262-021-02963-y
By:
- Tibbetts, Rachelle;
- Yeo, Kee Kiat;
- Muthugounder, Sakunthala;
- Lee, Meng-Hua;
- Jung, Cham;
- Porras-Corredor, Tania;
- Sheard, Michael A.;
- Asgharzadeh, Shahab
Publication type:
Article
CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 57, doi. 10.1007/s00262-021-02962-z
By:
- Xiao, Nan;
- Li, Kangshuai;
- Zhu, Xiaodong;
- Xu, Bin;
- Liu, Xuefeng;
- Lei, Ming;
- Sun, Hui-Chuan
Publication type:
Article
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 45, doi. 10.1007/s00262-021-02960-1
By:
- Zurlo, Ina Valeria;
- Schino, Mattia;
- Strippoli, Antonia;
- Calegari, Maria Alessandra;
- Cocomazzi, Alessandra;
- Cassano, Alessandra;
- Pozzo, Carmelo;
- Di Salvatore, Mariantonietta;
- Ricci, Riccardo;
- Barone, Carlo;
- Bria, Emilio;
- Tortora, Giampaolo;
- Larocca, Luigi Maria;
- Basso, Michele;
- Martini, Maurizio
Publication type:
Article
Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literature.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 39, doi. 10.1007/s00262-021-02959-8
By:
- Zhao, Guoxing;
- Wei, Runhong;
- Feng, Lei;
- Wu, Yi;
- He, Feng;
- Xiao, Mingxing;
- Cheng, Zhi
Publication type:
Article
Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 97, doi. 10.1007/s00262-021-02958-9
By:
- Wasiuk, Anna;
- Weidlick, Jeff;
- Sisson, Crystal;
- Widger, Jenifer;
- Crocker, Andrea;
- Vitale, Laura;
- Marsh, Henry C.;
- Keler, Tibor;
- He, Li-Zhen
Publication type:
Article
Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 25, doi. 10.1007/s00262-021-02957-w
By:
- Sun, Lin;
- Mu, Luwen;
- Zhou, Jing;
- Tang, Wenjie;
- Zhang, Linqi;
- Xie, Sidong;
- Chen, Jingbiao;
- Wang, Jin
Publication type:
Article
Reduced frequency of cytotoxic CD56dim CD16+ NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 13, doi. 10.1007/s00262-021-02956-x
By:
- Pánisová, Elena;
- Lünemann, Anna;
- Bürgler, Simone;
- Kotur, Monika;
- Lazarovici, Julien;
- Danu, Alina;
- Kaulfuss, Meike;
- Mietz, Juliane;
- Chijioke, Obinna;
- Münz, Christian;
- Busson, Pierre;
- Berger, Christoph;
- Ghez, David;
- Azzi, Tarik
Publication type:
Article
Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 189, doi. 10.1007/s00262-021-02954-z
By:
- Yokota, Chisato;
- Kagawa, Naoki;
- Takano, Koji;
- Chiba, Yasuyoshi;
- Kinoshita, Manabu;
- Kijima, Noriyuki;
- Oji, Yusuke;
- Oka, Yoshihiro;
- Sugiyama, Haruo;
- Tsuboi, Akihiro;
- Izumoto, Shuichi;
- Kishima, Haruhiko;
- Hashimoto, Naoya
Publication type:
Article
Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 85, doi. 10.1007/s00262-021-02953-0
By:
- Schuettfort, Victor M.;
- Pradere, Benjamin;
- Trinh, Quoc-Dien;
- D'Andrea, David;
- Quhal, Fahad;
- Mostafaei, Hadi;
- Laukhtina, Ekaterina;
- Mori, Keiichiro;
- Sari Motlagh, Reza;
- Rink, Michael;
- Karakiewicz, Pierre I.;
- Chlosta, Piotr;
- Yuen-Chun Teoh, Jeremy;
- Lotan, Yair;
- Scherr, Douglas;
- Abufaraj, Mohammad;
- Moschini, Marco;
- Shariat, Shahrokh F.
Publication type:
Article
STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 177, doi. 10.1007/s00262-021-02952-1
By:
- Andersen, Morten N.;
- Andersen, Niels F.;
- Lauridsen, Kristina L.;
- Etzerodt, Anders;
- Sorensen, Boe S.;
- Abildgaard, Niels;
- Plesner, Trine;
- Hokland, Marianne;
- Møller, Holger J.
Publication type:
Article
Intratumoral Foxp3+RORγt+ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 1, doi. 10.1007/s00262-021-02950-3
By:
- Fei, Yuchao;
- Cao, Yifan;
- Gu, Yun;
- Fang, Hanji;
- Chen, Yifan;
- Wang, Jieti;
- Liu, Xin;
- Lv, Kunpeng;
- He, Xudong;
- Lin, Chao;
- Liu, Hao;
- Li, He;
- He, Hongyong;
- Li, Ruochen;
- Zhang, Heng;
- Zhang, Weijuan
Publication type:
Article

Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 1

Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma.

Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.

ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC.

Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30.

CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1<sup>+</sup> CD8<sup>+</sup> T cells.

SIRPα-specific monoclonal antibody enables antibody-dependent phagocytosis of neuroblastoma cells.

Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.

PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.

Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.

CD74<sup>+</sup> macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma.

Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer.

Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literature.

Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice.

Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.

Reduced frequency of cytotoxic CD56<sup>dim</sup> CD16<sup>+</sup> NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma.

Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.

Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer.

STAT3 is over-activated within CD163<sup>pos</sup> bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS.

Intratumoral Foxp3<sup>+</sup>RORγt<sup>+</sup> T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients.